Le Registre des lobbyistes
Coalition pour de meilleurs médicaments / Best Medicines Coalition
Objets | Détails | Catégories |
---|---|---|
Santé
|
Discuss Canada's response to the proposed bulk importation of medications from Canada to the United States
|
Politique ou Programme, Règlement
|
Santé
|
Ensure access to a comprehensive range of medicines and vaccines in Canada and protect access to clinical trials, while helping to rebuild domestic capacities to develop and make drugs and vaccines.
|
Politique ou Programme
|
Santé
|
Ensure patient organizations are consulted and provide feedback on policies, processes, patient representation and other initiatives from Canada's Drug Agency.
|
Politique ou Programme
|
Santé
|
Learn more about and provide feedback on plans around COVID-19 vaccines, including protein based ones.
|
Politique ou Programme
|
Santé
|
Provide feedback on regulations to address health product shortages in Canada.
|
Règlement
|
Santé
|
Provide input on a national strategy for drugs for rare diseases.
|
Politique ou Programme
|
Santé
|
Provide input on pharmacare.
|
Politique ou Programme
|
Santé
|
Provide input on proposed agile regulations and guidance for licensing drugs and medical devices.
|
Règlement
|
Santé
|
Recommend that the government and regulators adopt proactive approaches to communicating drug supply and shortages issues and measures to address them.
|
Règlement, Politique ou Programme
|
Santé
|
Recommend that the government study and provide public interest funding so that the voices of patients, their needs and interests can be more adequately represented in public policy and regulatory matters.
|
Subvention, Contribution ou autre avantage financier, Politique ou Programme
|
Santé
|
Recommend the creation of a Chief Patient Officer.
|
Politique ou Programme
|
Santé
|
Recommend the creation of a Patient Ombudsman.
|
Politique ou Programme
|
Santé
|
Share patient groups perspectives on drug pricing and access to medications/vaccines/clinical trials, specifically regulations and guidelines related to the Patented Medicine Prices Review Board, along with feedback on their policies and practices, and processes related to PMPRB.
|
Politique ou Programme, Règlement
|